Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ETHZilla Corp Director's Dealing 2020

Dec 7, 2020

33039_dirs_2020-12-07_0b824377-5542-4b07-b264-4f8fcd19f98e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 180 Life Sciences Corp. (ATNF)
CIK: 0001690080
Period of Report: 2020-12-03

Reporting Person: Gold Lawrence Marshall (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-12-03 Stock Option (Right to Buy) $2.49 A 25000 Acquired 2030-12-03 Common Stock (25000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 0 Direct

Footnotes

F1: The Stock Options were granted to the Reporting Person pursuant to the Issuer's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) pursuant to Rule 16b-3.

F2: The options vest in equal monthly installments over the 12 months after the grant date (on the 3rd of each month), subject to the Reporting Person's continued service to the Company on such vesting dates.